124 related articles for article (PubMed ID: 31889295)
1. Activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
Acta Neurol Scand; 2020 May; 141(5):380-387. PubMed ID: 31889295
[TBL] [Abstract][Full Text] [Related]
2. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
J Neurol; 2020 Nov; 267(11):3235-3242. PubMed ID: 32542526
[TBL] [Abstract][Full Text] [Related]
3. Disease burden of myotonic dystrophy type 1.
Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Gorman G; Turner C; Lochmüller H
J Neurol; 2019 Apr; 266(4):998-1006. PubMed ID: 30788616
[TBL] [Abstract][Full Text] [Related]
4. How to capture activities of daily living in myotonic dystrophy type 2?
Montagnese F; Rastelli E; Stahl K; Massa R; Schoser B
Neuromuscul Disord; 2020 Oct; 30(10):796-806. PubMed ID: 32888768
[TBL] [Abstract][Full Text] [Related]
5. Functioning and disability in adults with myotonic dystrophy type 1.
Kierkegaard M; Harms-Ringdahl K; Holmqvist LW; Tollbäck A
Disabil Rehabil; 2011; 33(19-20):1826-36. PubMed ID: 21254917
[TBL] [Abstract][Full Text] [Related]
6. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
7. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
Raymond K; Levasseur M; Mathieu J; Gagnon C
Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
[TBL] [Abstract][Full Text] [Related]
8. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
[TBL] [Abstract][Full Text] [Related]
9. Accomplishment of instrumental activities of daily living and its relationship with cognitive functions in adults with myotonic dystrophy type 1 childhood phenotype: an exploratory study.
Tremblay M; Muslemani S; Côté I; Gagnon C; Fortin J; Gallais B
BMC Psychol; 2021 Apr; 9(1):56. PubMed ID: 33865455
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
[TBL] [Abstract][Full Text] [Related]
11. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
[TBL] [Abstract][Full Text] [Related]
12. Daily activity performance in congenital and childhood forms of myotonic dystrophy type 1: a population-based study.
Eriksson BM; Ekström AB; Peny-Dahlstrand M
Dev Med Child Neurol; 2020 Jun; 62(6):723-728. PubMed ID: 31701525
[TBL] [Abstract][Full Text] [Related]
13. Assessing upper extremity capacity as a potential indicator of needs related to household activities for rehabilitation services in people with myotonic dystrophy type 1.
Raymond K; Auger LP; Cormier MF; Vachon C; St-Onge S; Mathieu J; Noreau L; Gagnon C
Neuromuscul Disord; 2015 Jun; 25(6):522-9. PubMed ID: 25953319
[TBL] [Abstract][Full Text] [Related]
14. Instrumental activities of daily living in adults with the DM1 childhood phenotype: going beyond motor impairments.
Muslemani S; Gagnon C; Gallais B
Neuromuscul Disord; 2022 Apr; 32(4):313-320. PubMed ID: 35339341
[TBL] [Abstract][Full Text] [Related]
15. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.
Okkersen K; Jimenez-Moreno C; Wenninger S; Daidj F; Glennon J; Cumming S; Littleford R; Monckton DG; Lochmüller H; Catt M; Faber CG; Hapca A; Donnan PT; Gorman G; Bassez G; Schoser B; Knoop H; Treweek S; van Engelen BGM;
Lancet Neurol; 2018 Aug; 17(8):671-680. PubMed ID: 29934199
[TBL] [Abstract][Full Text] [Related]
16. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
van Engelen B;
Trials; 2015 May; 16():224. PubMed ID: 26002596
[TBL] [Abstract][Full Text] [Related]
17. Losing the ability in activities of daily living in the oldest old: a hierarchic disability scale from the Newcastle 85+ study.
Kingston A; Collerton J; Davies K; Bond J; Robinson L; Jagger C
PLoS One; 2012; 7(2):e31665. PubMed ID: 22355385
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
Jean S; Richer L; Laberge L; Mathieu J
Orphanet J Rare Dis; 2014 Nov; 9():186. PubMed ID: 25424323
[TBL] [Abstract][Full Text] [Related]
19. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
[TBL] [Abstract][Full Text] [Related]
20. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ).
Hermans MC; Faber CG; De Baets MH; de Die-Smulders CE; Merkies IS
Neuromuscul Disord; 2010 May; 20(5):310-8. PubMed ID: 20363134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
